ENHANCED PROVIDES CLINICAL TRIAL UPDATE - FIRST OF ITS KIND STUDY CONTINUES WITH ATHLETES HEALTHY & SAFE TO COMPETE

Enhanced Releases Aggregate Substance Usage Data Ahead of Competition With Study Now Available for Review on Clinicaltrials.org 91% of Athletes in Trial Used Testosterone as Part of Individualized Protocols NEW YORK, May 20, 2026 /PRNewswire/ -- Enhanced (NYSE: ENHA), the elite sports...